| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2008 | US20080311098 Compounds and methods for modulating the immune response against antigens |
| 12/18/2008 | US20080311090 Methods for inhibition of proliferative disease, including hepatocellular carcinoma |
| 12/18/2008 | US20080311079 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 12/18/2008 | US20080311077 Antiviral Compounds |
| 12/18/2008 | US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents |
| 12/18/2008 | US20080311075 Hepatitis C Virus Inhibitors |
| 12/18/2008 | US20080311074 Inhibitors against activation of NF-kappaB |
| 12/18/2008 | US20080311072 Preparation of Soluble and Colloidal Molecularly Imprinted Polymers by Living Polymerization |
| 12/18/2008 | US20080311070 Ophthalmic composition with hyaluronic acid |
| 12/18/2008 | US20080311064 Higher Performance Capsule Particles |
| 12/18/2008 | US20080311058 Stable high internal phase emulsions and compositions comprising the same |
| 12/18/2008 | US20080311054 Contains oct-2-ynoic acid methyl ester; sugarless chewing gum |
| 12/18/2008 | US20080311052 Isis Pharmaceuticals, Inc. |
| 12/18/2008 | US20080311049 Thermoforming by extrusion without discoloration; controlled release |
| 12/18/2008 | US20080311045 Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| 12/18/2008 | US20080311041 Water-Soluble, Fluorescent Compounds for Detection of Potassium Ions |
| 12/18/2008 | US20080311040 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA |
| 12/18/2008 | US20080311039 Therapeutic and Prognostic Factor Yy1 in Human Cancer |
| 12/18/2008 | US20080311037 Compounds which bind PSMA and uses thereof |
| 12/18/2008 | DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 12/18/2008 | DE60132178T2 CRISTALLINSALZE VON 7-i4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-iMETHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL -(3R,5S)-3,5-DIHYDROXYHEPT-6-ENSÄURE CRISTALLI SALTS OF 7-I4 (4-fluorophenyl) -6-isopropyl-2-iMETHYL (methylsulfonyl) PYRIMIDIN AMINO-5-YL - (3R, 5S) -3,5-dihydroxyhept-6-enoic acid |
| 12/18/2008 | DE102007049063A1 Leberschutzverbindungen des Cyclohexenontyps aus Antrodia camphorata Hepatoprotective compounds of Antrodia camphorata from Cyclohexenontyps |
| 12/18/2008 | DE102007043186A1 Cyclohexenonverbidungen aus Antrodia camphorata zur Behandlung von Autoimmunerkrankungen From Antrodia camphorata Cyclohexenonverbidungen for the treatment of autoimmune diseases |
| 12/18/2008 | DE102007040935A1 Deep face folds treatment involves utilizing structured stand geometrically and spatially, made of hyaluronic acid or collagen, where long traces are spayed as carrier in middle dermis along fold to be treated |
| 12/18/2008 | DE102007027800A1 Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung Substituted bicyclic heteroaryl compounds and their use |
| 12/18/2008 | DE102007027799A1 Substituierte Furopyrimidine und ihre Verwendung Substituted Furopyrimidine and their use |
| 12/18/2008 | DE102007027637A1 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17ß-cyano-19-nor-androst-4-ene derivative, its use and pharmaceutical compositions containing the derivative |
| 12/18/2008 | DE102007027636A1 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17ß-cyano-18a-homo-19-nor-androst-4-ene derivative, the use of the derivative and pharmaceutical compositions containing them |
| 12/18/2008 | DE102007027635A1 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17ß-cyano-19-androst-4-ene derivative, its use and pharmaceutical compositions containing the derivative |
| 12/18/2008 | DE102007027067A1 Verfahren zur Herstellung eines Arzneimittels enthaltend Vardenafil Hydrochlorid Trihydrat A process for preparing a pharmaceutical composition comprising vardenafil hydrochloride trihydrate |
| 12/18/2008 | DE102007005045B4 Phenothiazin Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Phenothiazine derivatives, processes for their preparation and their use as medicaments |
| 12/18/2008 | CA2727528A1 Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system |
| 12/18/2008 | CA2726734A1 Hdac inhibitor ms-275 and aromatase inhibitors for the treatment of cancer |
| 12/18/2008 | CA2694871A1 Chemical compounds |
| 12/18/2008 | CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer |
| 12/18/2008 | CA2693126A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists |
| 12/18/2008 | CA2692922A1 Azaindole-indole coupled derivatives, preparation methods and uses thereof |
| 12/18/2008 | CA2692251A1 Nutritional compositions |
| 12/18/2008 | CA2692050A1 Thiazoliopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 12/18/2008 | CA2692042A1 Compositions and methods for treating obesity and related disorders |
| 12/18/2008 | CA2691623A1 Methods and compositions for treating phenylketonuria |
| 12/18/2008 | CA2691563A1 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
| 12/18/2008 | CA2690959A1 17.beta.-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 12/18/2008 | CA2690913A1 Ire-1alpha inhibitors |
| 12/18/2008 | CA2690874A1 Improvements in and relating to mammalian reproduction |
| 12/18/2008 | CA2690858A1 Reduced-mass, long-acting dosage forms |
| 12/18/2008 | CA2690771A1 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | CA2690686A1 Amine compound and pharmaceutical use thereof |
| 12/18/2008 | CA2690674A1 Rnai inhibition of alpha-enac expression |
| 12/18/2008 | CA2690643A1 Oligonucleotides for modulation of target rna activity |
| 12/18/2008 | CA2690581A1 Compositions useful for treating gastroesophageal reflux disease |
| 12/18/2008 | CA2690569A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 12/18/2008 | CA2690567A1 New compounds |
| 12/18/2008 | CA2690486A1 New heteocyclic h3 antagonists |
| 12/18/2008 | CA2690485A1 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
| 12/18/2008 | CA2690468A1 New compounds 892 |
| 12/18/2008 | CA2690455A1 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases |
| 12/18/2008 | CA2690348A1 Morpholine derivative |
| 12/18/2008 | CA2690299A1 Piperazine and [1,4] diazepan derivatives as nk antagonists |
| 12/18/2008 | CA2690267A1 Small cationic antimicrobial peptides |
| 12/18/2008 | CA2690265A1 Mutual prodrugs and methods to treat cancer |
| 12/18/2008 | CA2690080A1 Urotensin ii receptor antagonists |
| 12/18/2008 | CA2690036A1 Pack |
| 12/18/2008 | CA2689948A1 Gamma secretase modulators |
| 12/18/2008 | CA2689934A1 Therapeutic pyrazolonaphthyridine derivatives |
| 12/18/2008 | CA2689930A1 Gamma secretase modulators |
| 12/18/2008 | CA2689662A1 Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne |
| 12/18/2008 | CA2689638A1 Pde inhibitors for the treatment of hearing impairment |
| 12/18/2008 | CA2689607A1 Kinase inhibitor compounds |
| 12/18/2008 | CA2689592A1 Composition and uses of a retinoid, an anti-irritant compound and benzoyl peroxide, in acne |
| 12/18/2008 | CA2689563A1 17.beta.-cyano-18a-homo-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 12/18/2008 | CA2689561A1 Substituted 2- [2- (phenyl) ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators |
| 12/18/2008 | CA2689507A1 Aldosterone induced elastin production |
| 12/18/2008 | CA2689217A1 Carboxamide heterocyclic cgrp receptor antagonists |
| 12/18/2008 | CA2689212A1 Terpenes with antifungal activity against malassezia yeasts |
| 12/18/2008 | CA2689209A1 Piperazine compounds having herbicidal action |
| 12/18/2008 | CA2689137A1 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 12/18/2008 | CA2689102A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 12/18/2008 | CA2689079A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
| 12/18/2008 | CA2688641A1 Control of ectoparasites with mitochondrial complex 1 inhibitors |
| 12/18/2008 | CA2688472A1 Biphenylcarboxamide derivatives as hedgehog pathway modulators |
| 12/18/2008 | CA2688405A1 Therapeutic pyrazoloquinoline urea derivatives |
| 12/18/2008 | CA2688395A1 Therapeutic pyrazoloquinoline derivatives |
| 12/18/2008 | CA2688343A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
| 12/18/2008 | CA2688241A1 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 12/18/2008 | CA2688237A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 12/18/2008 | CA2688235A1 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology |
| 12/18/2008 | CA2688234A1 Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders |
| 12/18/2008 | CA2688208A1 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 12/18/2008 | CA2687979A1 Sustained delivery formulations of risperidone compounds |
| 12/18/2008 | CA2687751A1 Disaccharides for the treatment of tendons, ligaments and bones |
| 12/18/2008 | CA2687721A1 Crystalline forms of (r)-1-{2-[4'-(3-methoxy-propane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| 12/18/2008 | CA2687717A1 Formulations and methods for treating dry eye |
| 12/18/2008 | CA2687172A1 Anti-norovirus agent and composition containing the same |
| 12/18/2008 | CA2686834A1 Method of manufacturing a ruthenium complex |
| 12/18/2008 | CA2686833A1 Compositions and methods for modulating inflammation using fluoroquinolones |
| 12/18/2008 | CA2686548A1 Concentrate esmolol |
| 12/18/2008 | CA2686223A1 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 12/18/2008 | CA2684886A1 Dual-acting benzoimidazole antihypertensive agents |
| 12/18/2008 | CA2683313A1 Benefit agent containing delivery particle |